首页> 外文期刊>Seminars in Nuclear Medicine >Thematic planning: the role of the International Atomic Energy Agency in promoting education, medical research, and technology transfer among nuclear medicine communities of developing countries.
【24h】

Thematic planning: the role of the International Atomic Energy Agency in promoting education, medical research, and technology transfer among nuclear medicine communities of developing countries.

机译:主题计划:国际原子能机构在促进发展中国家核医学界之间的教育,医学研究和技术转让方面的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

One of the major mechanisms of implementing the International Atomic Energy Agency's (IAEA) programs in nuclear medicine has been through coordinated research projects (CRPs). In recent years, the IAEA has initiated a new type of CRP, called Doctoral CRP, in an attempt to further improve the effectiveness of its programs. The structure of the Doctoral CRP has been built on the structure of the existing CRP concept, but with a broader "thematic" approach. The word "thematic" indicates that these CRPs should both have a fairly broad scope and be designed so that their outcome, in terms of practical applications, might readily fit into the selected nuclear applications that are offered to Member States under the IAEA's mechanism for thematic planning. The Nuclear Medicine Section of IAEA's Division of Human Health initiated the first Doctoral CRP of IAEA in the year 2000, entitled, "Management of Liver Cancer Using Radionuclide Methods with Special Emphasis on Trans-Arterial Radio-conjugate Therapy and Internal Dosimetry." Since then, the CRP has accomplished several milestones, including development of a new therapeutic radiopharmaceutical ((188)Re lipiodol) and successfully carrying out Phase I and Phase II clinical trials on patients using the new therapeutic radiopharmaceutical.
机译:实施国际原子能机构(IAEA)核医学计划的主要机制之一是通过协调研究项目(CRP)。近年来,国际原子能机构启动了一种新型的CRP,称为Doctoral CRP,以试图进一步提高其计划的有效性。博士CRP的结构建立在现有CRP概念的结构之上,但是具有更广泛的“主题”方法。 “专题”一词表示这些CRP都应具有相当广泛的范围,其设计应使其结果在实际应用方面很容易适合根据IAEA主题机制向成员国提供的选定核应用。规划。 IAEA人类健康部门的核医学科于2000年启动了IAEA的首个博士CRP,其名称为“使用放射性核素方法管理肝癌,特别强调经动脉放射共轭疗法和内部剂量测定。”自那时以来,CRP已完成了多个里程碑,包括开发新的治疗性放射性药物((188)Re lipiodol)并成功使用新的治疗性放射性药物对患者进行了I期和II期临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号